CONSUMATORI
Condizioni di venditaContattiCercaSitemap
HOME
INTEGRATORI
QUALITA' CERTIFICATA
TESTIMONIANZE
OMEGA-3
RICERCA E SALUTE
Il FARMACISTA CONSIGLIA
LIBRI
OMEGOR IN FARMACIA
RISORSE
Bibliografia Scientifica
Domande e Risposte
Glossario
NEWSLETTER
U.G.A. NUTRACEUTICALS
E-SHOP OMEGOR
 
RISORSE / Bibliografia Scientifica
Stampa Segnala l'articolo
Indietro

Marangell LB et al. (2003)
OBJECTIVE: This study was an evaluation of the omega-3 fatty acid docosahexaenoic acid (DHA) for the treatment of major depression. METHOD: Thirty-six depressed patients were randomly assigned to receive DHA, 2 g/day, or placebo for 6 weeks. Response was defined a priori as a > or =50% reduction in the score on the Montgomery-Asberg Depression Rating Scale. Thirty-five participants were evaluable; 18 received DHA, and 17 received placebo. RESULTS: Response rates were 27.8% in the DHA group and 23.5% in the placebo group. The difference in response rates between groups did not reach statistical significance. CONCLUSIONS: This trial failed to show a significant effect of DHA monotherapy in subjects with major depression.
Stampa Segnala l'articolo
Indietro
 Credits ©2006-2010 - U.G.A. Nutraceuticals S.r.l. - P.IVA 02801680543     Company Info